(株)ペルセウスプロテオミクスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4882/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2022/01/28 | 日証協 | 48,011株 | -3.23% | 2,400株 | +9.09% | 274,522株 | -1.22% | 9,200株 | +21.05% |
| 2022/01/21 | 日証協 | 49,611株 | -2.36% | 2,200株 | -88.6% | 277,922株 | +1.05% | 7,600株 | -49.34% |
| 2022/01/14 | 日証協 | 50,811株 | +8.08% | 19,300株 | +704.17% | 275,022株 | +1.48% | 15,001株 | -53.3% |
| 2022/01/07 | 日証協 | 47,011株 | +0.43% | 2,400株 | -64.18% | 271,021株 | +15.86% | 32,120株 | +234.58% |
| 2021/12/30 | 日証協 | 46,811株 | 0% | 6,700株 | 0% | 233,921株 | 0% | 9,600株 | 0% |
| 2021/12/24 | 日証協 | 46,811株 | -6.59% | 6,700株 | -12.99% | 233,921株 | -0.72% | 9,600株 | +18.52% |
| 2021/12/17 | 日証協 | 50,111株 | -35.68% | 7,700株 | +54% | 235,621株 | -8.75% | 8,100株 | -44.96% |
| 2021/12/10 | 日証協 | 77,911株 | +0.52% | 5,000株 | -48.98% | 258,205株 | +1.89% | 14,716株 | +21.62% |
| 2021/12/03 | 日証協 | 77,511株 | 0% | 9,800株 | -13.27% | 253,405株 | -0.16% | 12,100株 | +210.26% |
| 2021/11/26 | 日証協 | 77,511株 | +1.04% | 11,300株 | -24.67% | 253,805株 | +1.56% | 3,900株 | -72.56% |
| 2021/11/19 | 日証協 | 76,711株 | -18.58% | 15,000株 | -48.1% | 249,905株 | -3.55% | 14,214株 | -13.91% |
| 2021/11/05 | 日証協 | 82,911株 | +7.1% | 27,800株 | +62.47% | 226,981株 | +1.7% | 23,800株 | +186.75% |
| 2021/10/29 | 日証協 | 77,411株 | +3.63% | 17,111株 | +249.2% | 223,181株 | -0.44% | 8,300株 | +29.49% |
| 2021/10/22 | 日証協 | 74,700株 | -22.91% | 4,900株 | -85.24% | 224,171株 | -4.64% | 6,410株 | -76.61% |
| 2021/10/15 | 日証協 | 96,900株 | +43.13% | 33,200株 | +526.42% | 235,071株 | +8.64% | 27,400株 | +124.31% |
| 2021/10/08 | 日証協 | 67,700株 | -10.45% | 5,300株 | -67.88% | 216,371株 | +1.84% | 12,215株 | +7.95% |
| 2021/10/01 | 日証協 | 75,600株 | -5.03% | 16,500株 | +1.23% | 212,456株 | -2.02% | 11,315株 | +28.58% |
| 2021/09/24 | 日証協 | 79,600株 | +12.43% | 16,300株 | +16.43% | 216,841株 | +2.02% | 8,800株 | -15.38% |
| 2021/09/17 | 日証協 | 70,800株 | +1.29% | 14,000株 | +218.18% | 212,541株 | -2.34% | 10,400株 | +26.83% |
※株式分割は考慮していませんのでご注意ください。
Page Top